DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,042 filers reported holding DANAHER CORPORATION in Q1 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $620,250 | +3.3% | 2,500 | 0.0% | 0.17% | -14.4% |
| Q2 2023 | $600,675 | -4.8% | 2,500 | 0.0% | 0.20% | -12.2% |
| Q1 2023 | $630,775 | -5.0% | 2,500 | 0.0% | 0.23% | +14.5% |
| Q4 2022 | $664,175 | +2.8% | 2,500 | 0.0% | 0.20% | -20.9% |
| Q3 2022 | $646,000 | +1.9% | 2,500 | 0.0% | 0.25% | -15.7% |
| Q2 2022 | $634,000 | -13.6% | 2,500 | 0.0% | 0.30% | -16.7% |
| Q1 2022 | $734,000 | -10.8% | 2,500 | 0.0% | 0.36% | -39.6% |
| Q4 2021 | $823,000 | +8.0% | 2,500 | 0.0% | 0.60% | +36.7% |
| Q3 2021 | $762,000 | +13.6% | 2,500 | 0.0% | 0.44% | +678.6% |
| Q2 2021 | $671,000 | +19.2% | 2,500 | 0.0% | 0.06% | -21.1% |
| Q1 2021 | $563,000 | +1.3% | 2,500 | 0.0% | 0.07% | +24.6% |
| Q4 2020 | $556,000 | +3.2% | 2,500 | 0.0% | 0.06% | -6.6% |
| Q3 2020 | $539,000 | +21.7% | 2,500 | 0.0% | 0.06% | +48.8% |
| Q2 2020 | $443,000 | +15.1% | 2,500 | -9.9% | 0.04% | -48.1% |
| Q1 2020 | $385,000 | +0.3% | 2,775 | +11.0% | 0.08% | -19.4% |
| Q4 2019 | $384,000 | +6.1% | 2,500 | 0.0% | 0.10% | +133.3% |
| Q3 2019 | $362,000 | -13.0% | 2,500 | -13.9% | 0.04% | -16.0% |
| Q2 2019 | $416,000 | +8.3% | 2,904 | 0.0% | 0.05% | +16.3% |
| Q1 2019 | $384,000 | +25.9% | 2,904 | -1.6% | 0.04% | -27.1% |
| Q4 2018 | $305,000 | -5.0% | 2,950 | 0.0% | 0.06% | +136.0% |
| Q3 2018 | $321,000 | +10.7% | 2,950 | +0.4% | 0.02% | +4.2% |
| Q2 2018 | $290,000 | +7.0% | 2,939 | +6.2% | 0.02% | -42.9% |
| Q1 2018 | $271,000 | +3.8% | 2,768 | -1.3% | 0.04% | -6.7% |
| Q4 2017 | $261,000 | +8.3% | 2,804 | 0.0% | 0.04% | +9.8% |
| Q3 2017 | $241,000 | +14.2% | 2,804 | +12.2% | 0.04% | -30.5% |
| Q2 2017 | $211,000 | -1.4% | 2,500 | 0.0% | 0.06% | +18.0% |
| Q1 2017 | $214,000 | -15.4% | 2,500 | 0.0% | 0.05% | -26.5% |
| Q2 2016 | $253,000 | +6.3% | 2,500 | 0.0% | 0.07% | -12.8% |
| Q1 2016 | $238,000 | +2.6% | 2,500 | 0.0% | 0.08% | -4.9% |
| Q4 2015 | $232,000 | +8.9% | 2,500 | 0.0% | 0.08% | -6.8% |
| Q3 2015 | $213,000 | -0.5% | 2,500 | 0.0% | 0.09% | +2.3% |
| Q2 2015 | $214,000 | – | 2,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |